Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
08/2007
08/01/2007CN101007069A A medicinal composition for treating oral ulcer and its preparation method
08/01/2007CN101007066A Ointment for treating pressure ulcers
08/01/2007CN101007065A Cool tea buccal tablets and its preparation method
08/01/2007CN101007064A Isolation and purification method of lotus leaf extract by macroporous resin and its application thereof
08/01/2007CN101007063A Preparation method of lotus leaf extract and use thereof
08/01/2007CN101007062A Traditional Chinese medicine composition capable of resisting infection
08/01/2007CN101007060A A medicinal composition for treating respiratory tract infectious disease and its preparation method
08/01/2007CN101007059A A lonicera and scutellaria drip pill and its preparation method
08/01/2007CN101007058A Medicinal composition for treating bronchial asthma, chronic bronchitis and emphysema
08/01/2007CN101007056A An antitumor medicinal composition and its preparation method
08/01/2007CN101007053A Capsule for treating gynecological diseases and preparation method and quality-control method
08/01/2007CN101007048A Preparation method of a compound glutamine medicine composition
08/01/2007CN101007047A An antitumor medicine composition and its preparation method
08/01/2007CN101007041A A medicinal composition for treating viral infection of upper respiratory tract and its preparation method
08/01/2007CN101007039A Chewing gum capable of promoting sexual function and its preparation method
08/01/2007CN101007036A A traditional Chinese medicine capable of decreasing blood sugar and benefiting kidney
08/01/2007CN101007035A Application of notoginseng glycol saponins and its preparation for treating memory deterioration, preventing and controlling Alzheimer disease
08/01/2007CN101007034A Extraction technology of alkaloids from fresh catharanthus roseus
08/01/2007CN101007032A Compound sulfathiazole sodium injection liquid and its preparation method
08/01/2007CN101007031A External applied Chinese medicinal powder for treating beriberi
08/01/2007CN101007029A Orally administered traditional Chinese medicinal composition for treating hepatitis A and B
08/01/2007CN101007024A Spirulina containing active peptide, protease and protein kinase, and its processing method and application
08/01/2007CN101007022A Application of turtle oil in preparation of drug for treating burn
08/01/2007CN101007018A Bacteriostat-free water-soluble vitamin freeze-dried preparation for injection
08/01/2007CN101007017A Extract of traditional Chinese medicine having alpha-glucosidase inhibitor activity and its application
08/01/2007CN101007014A A compound puerarin preparation
08/01/2007CN101007013A Liposome of astragaloside IV and its medicinal preparation
08/01/2007CN101007011A Ginsenoside Rh2 self-emulsifying composition and its preparation method
08/01/2007CN101007008A Ciclesonide medicinal spraying agent and its preparation method
08/01/2007CN101007007A Cefquinome medicinal composition for injection capable of being stored stably and dissolved easily in water
08/01/2007CN101007005A Preparation of sublingual administered nalmefene hydrochloride
08/01/2007CN101007003A A stable torasemide injection and its preparation method
08/01/2007CN101007002A Huperzine A pellets preparation and its preparation method
08/01/2007CN101006998A Taxol drug supported by polymer nanoparticles and its preparation method
08/01/2007CN101006997A Compound taxol and its derivative docetaxel fat emulsion and preparation method
08/01/2007CN101006996A A drug for treating calculus in urinary system and hyperuricemia and its preparation method
08/01/2007CN101006994A Enteric-coated capsules of allimin and its preparation method
08/01/2007CN101006993A Soluble slow release external applied contraceptive
08/01/2007CN101006992A Propofol freeze-dried emulsion and its preparing method
08/01/2007CN101006991A Slow release preparation of berberine
08/01/2007CN101006990A Slow release preparation of cilostazol
08/01/2007CN101006989A Slow release preparation of alginic sodium diester
08/01/2007CN101006988A Slow release preparation of puerarin
08/01/2007CN101006987A Slow release preparation of erythromycin
08/01/2007CN101006986A Medicinal composition containing mycophonolate mofetil and its preparation method
08/01/2007CN101006985A Pharmacological composition
08/01/2007CN101006984A An injection preparation containing salvianolic acid A and extract of panax natoginseng, and its preparation method and application
08/01/2007CN101006983A Preparation of composite drug-loaded nanoparticles of carboxyl-chitosan and chitosan modified by glycyrrhizanates
08/01/2007CN101006982A Anticancer medicine composition of taxane and its synergist
08/01/2007CN101006981A Slow released injection containing taxane and platinum
08/01/2007CN101006980A Anticancer composition containing taxane and alkaloids
08/01/2007CN101006979A Anticancer composition containing taxane and topoenzyme inhibitor
08/01/2007CN101006978A Anticancer medicinal composition containing taxane and alkylating agents
08/01/2007CN101006977A Anticancer medicinal composition containing taxane and hormones drug
08/01/2007CN101006976A Anticancer medicinal composition of loaded taxane and its synergist
08/01/2007CN101006975A An oral medicine preparation containing salvianolic acid A and extract of panax natoginseng, and its preparation method and application
08/01/2007CN101006974A Ophthalmic gel and its preparation method
07/2007
07/31/2007US7250546 Patch with an adhesive of a styrene-isoprene-styrene block copolymer, polyisobutylene, a tackifier, a plasticizer and a polyisobutylene; less skin stimulation, excellent in long time store stability, heat stability, favorable tack during use
07/31/2007US7250454 Conductive nanocomposite films
07/31/2007US7250404 Lipid-mediated polynucleotide administration to deliver a biologically active peptide and to induce a cellular immune response
07/31/2007US7250403 Administration of immunomodulatory polynucleotide microcarrier complexes featuring a polynucleotide comprising at least one immunostimulatory sequence bound to a biodegradable microcarrier or noncarrier
07/31/2007US7250177 Multiblock biodegradable hydrogels for drug delivery and tissue treatment
07/31/2007US7250176 Administering to the patient in need thereof a therapeutically effective amount of a composition in solid form comprising amoxicillin and potassium clavulanate and comprising a first release phase and a second release phase
07/31/2007US7250174 Cosmetic, personal care, cleaning agent, and nutritional supplement compositions and methods of making and using same
07/31/2007US7250154 Radio-opaque polymeric biomaterials
07/31/2007US7250153 Contrast media formulations having improved biological tolerance
07/31/2007US7250043 Catheter for modification of agent formulation
07/31/2007US7249599 Process and apparatus for producing inhalable medicaments
07/31/2007CA2260584C Androsterone derivatives for inhibiting dna binding of ap-1 and airway smooth muscle proliferation
07/31/2007CA2258683C Oral composition comprising a triazole antifungal compound
07/31/2007CA2241188C Hydrogel wound dressing and the method of making and using the same
07/31/2007CA2240705C Cyclosporin-containing soft capsule preparations
07/31/2007CA2214480C The production of carotenoid preparations in the form of coldwater-dispersible powders, and the use of the novel carotenoid preparations
07/31/2007CA2207674C Moisture containing compositions that are spreadable onto and adherable to biomembranes, methods of making and use thereof
07/31/2007CA2186260C Composition comprising morphine, polypyrrolidone and a polyalkyleneoxide
07/31/2007CA2179907C Use of bicontinuous microemulsions as pressure sensitive adhesives
07/31/2007CA2160767C Injectable microdispersions for soft tissue repair and augmentation
07/26/2007WO2007084908A2 An anti-microbial material and method of making the same
07/26/2007WO2007084676A2 Stabilization of paricalcitol using chlorobutyl or chlorinated butyl stoppers
07/26/2007WO2007084617A2 Film bandage for mucosal administration of actives
07/26/2007WO2007084541A2 Central administration of stable formulations of therapeutic agents for cns conditions
07/26/2007WO2007084468A2 Photodynamic cosmetic procedure and healing method
07/26/2007WO2007084313A2 Abuse resistant transdermal drug delivery
07/26/2007WO2007084247A2 Stable therapeutic formulations
07/26/2007WO2007084212A2 Biologically active composition comprising ethylcellulose
07/26/2007WO2007084068A1 Pharmaceutical formulations comprising dextran with molecular weight of 1.0-100kda and processes for their preparation
07/26/2007WO2007083763A1 Method for production of emulsion preparation comprising physiologically active peptide, and kit for production of the preparation
07/26/2007WO2007083698A1 Laminated microcapsule sheet and process for production thereof
07/26/2007WO2007083679A1 Novel film-coated tablet
07/26/2007WO2007083522A1 Gel-forming composition for medical use, devices for the application of the composition, and drug release controlling carrier
07/26/2007WO2007083402A1 Nutritional supplement for promotion of hair growth and/or hair restoration
07/26/2007WO2007083323A2 Modified release oral dosage form comprising desmopressin
07/26/2007WO2007083309A2 Method and apparatus for forming delivery devices for oral intake of an agent
07/26/2007WO2007083164A2 Liquid electrostatic spray composition
07/26/2007WO2007082979A1 A solid lyophilized taxane composition, a method for preparing said solid composition, a pharmaceutical formulation and a kit for said formulation
07/26/2007WO2007082978A1 Taxane pharmaceutical formulation, solid taxane composition, method for preparing the solid taxane composition, composition for solubilising said solid taxane composition and set of elements (kit) for the injectable taxane formulation
07/26/2007WO2007082936A1 Use of amphiphilic self-assembling proteins for formulating poorly water-soluble effect substances
07/26/2007WO2007082809A1 Pharmaceutical composition and process
07/26/2007WO2007082770A1 Coated formulations
07/26/2007WO2007082764A1 Pharmaceutical composition comprising amorphous atorvastatin